-
CPI-0610
- names:
CPI-0610
- CAS号:
1380087-89-7
MDL Number: - MF(分子式): C20H16ClN3O2 MW(分子量): 365.81
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM002898-10mg | 10mg | 99.95% | ¥ 2025.00 | ¥ 2025.00 | 2-3天 | ¥ 0.00 | ||
| YZM002898-5mg | 5mg | 99.95% | ¥ 1261.00 | ¥ 1261.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 1380087-89-7 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C20H16ClN3O2 |
| 分子量 Molecular Weight | 365.81 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度100 mg/mL(273.37 mM;Need ultrasonic) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
CPI-0610(CAS:1380087-89-7)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | CPI-0610 是一种有效的,选择性的,具有细胞活性的BET抑制剂,抑制BRD4-BD1的IC50值为 39 nM |
| Introduction | CPI610 is a potent, selective, and cellctiveBETinhibitor. CPI610 inhibitsBRD4D1with anIC50of 39 nM, and with anEC50value of 0.18 μM forMYC. |
| Application1 | |
| Application2 | |
| Application3 |
CPI-0610 是一种有效的,选择性的,具有细胞活性的BET抑制剂,抑制BRD4-BD1的IC50值为 39 nM。CPI-0610 对MYC的EC50值为 0.18 μM。CPI-0610 is a potent, selective, and cell-activeBETinhibitor. CPI-0610 inhibitsBRD4-BD1with anIC50of 39 nM, and with anEC50value of 0.18 μM forMYC[1].
【1】.Albrecht BK, et al. Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials. J Med Chem. 2016 Feb 25;59(4):1330-9.
【2】.Siu KT, et al. Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma. Leukemia. 2017 Aug;31(8):1760-1769.
【2】.Siu KT, et al. Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma. Leukemia. 2017 Aug;31(8):1760-1769.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


